Create an Account

LDL-c & PCSK9i in Clinical Cardiology

European experts discuss the importance of targeting LDL-c in patients at increased CV risk and the potential role of PCSK9 inhibition

Episodes 1-1 of 1

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00
    Register

    We’re glad to see you’re enjoying PACE-CME…
    but how about a more personalized experience?

    Register for free
    You are now leaving PACE-CME and going to a site run by another organization.

    Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.